Document is current
Any future updates will be listed below
-
Authors
Dzialach, Lukasz https://orcid.org/0000-0001-9283-4827
Sobolewska, Joanna https://orcid.org/0000-0003-0440-2851
Respondek, Wioleta
Wojciechowska-Luzniak, Agnieszka https://orcid.org/0000-0003-1520-7752
Kuca, Pawel https://orcid.org/0000-0003-2224-5554
Witek, Przemysław https://orcid.org/0000-0003-4512-4624
- License Information
-
More Information
Article History
Received: 14 August 2024
Accepted: 10 December 2024
First Online: 18 December 2024
Compliance with ethical standards
:
: Authors L.D. and P.W. reports receiving speaker fees and consulting fees from Recordati Rare Diseases. Author J.S., W.R., A.W-L., and P.K. declare no conflict of interest.
: The study was approved by the Ethics Committee of Medical University of Warsaw (permission number: AKBE/170/2024) and was performed in accordance with the Declaration of Helsinki.
: As this was a retrospective study on medical files and all the procedures being performed were part of the routine care, patient’s informed consent in the opinion of the local bioethics committee was not required. However, before etomidate infusion and after obtaining comprehensive information (including off-label use of etomidate), each patient signed informed consent for etomidate treatment and for the use of data obtained during treatment for scientific purposes, which is included in the patient’s medical history.
